ROIV

Roivant Sciences

• Benzinga·1d ago

  Transcript: Roivant Sciences Q1 2027 Earnings Conference Call

• Benzinga·5d ago

  Here’s How Much You Would Have Made Owning Roivant Sciences Stock In The Last 5 Years

• Seeking Alpha·6d ago

  Arbutus gains on plans to buy back 46M shares in tender offer

• TipRanks·09/26 17:00

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Roivant Sciences (ROIV) and Johnson & Johnson (JNJ)

• TipRanks·09/23 17:20

  Wainwright maintains confidence in Immunovant’s pipeline despite CLE setback

• NASDAQ·09/23 13:56

  Roivant's IMVT-1402 Shows Positive Trends In Lupus Skin Disease Study, But Misses Main Goal

• Benzinga·09/23 13:03

  Immunovant Ends Autoimmune Skin Disorder Program

• TipRanks·09/23 12:15

  Roivant Sciences price target raised to $41 from $37.50 at BofA

• Seeking Alpha·09/23 11:27

  Roivant slips as Immunovant faces trial setback for cutaneous lupus therapy

• TipRanks·09/23 11:10

  Roivant announces trial of IMVT-1402 did not reach statistical significance

• Benzinga·09/23 11:05

  Roivant And Immunovant Say Topline Results From Period 1 Of Proof-of-concept Trial of IMVT-1402 (Imeroprubart) For Cutaneous Lupus Erythematosus Did Not Achieve Statistical Significance On The Primary Endpoint

• TipRanks·09/23 11:00

  Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Roivant Sciences (ROIV)

• Simply Wall St·09/22 20:26

  Why Roivant Sciences (ROIV) Is Back In The Spotlight

• Seeking Alpha·09/20 18:57

  FDA, Duke-Margolis workshop to examine evidence standards for rare diseases

• Simply Wall St·09/19 10:19

  Did Positive PH ILD Trial Data Just Shift Roivant Stock Investment Narrative?